LARGE FAMILY FOR LARGE ACHIEVEMENTS
We develop modern prevention, diagnostics and therapy products for health preservation and improved quality of life.
Press centre
PRESS CENTAR / NEWS
Bosnalijek for the 21st Century
On Wednesday 28 March, Bosnalijek d.d. (Bosnalijek), the leading pharmaceutical company in Bosnia and Herzegovina, inaugurated a new Quality Control facility in Sarajevo.
MORE
ANNUAL REGULAR ASSEMBLY
Notice of convening annual regular assembly of Bosnalijek joint stock company
Pursuant to Article 230, paragraph (1) of Company Law (Official Gazette of FB&H, No. 81/15) and Article 48, paragraph (1) of valid Bosnalijek d.d. Statute (consolidated text No: 2830/2017 of 18.09.2017), and based on the Supervisory Board's Decision on Convening Annual Regular Assembly No. 1909/18 of 28.05.2018, we announce:
In detail
PRESS CENTAR / NEWS
Bosnalijek for the 21st Century
On Wednesday 28 March, Bosnalijek d.d. (Bosnalijek), the leading pharmaceutical company in Bosnia and Herzegovina, inaugurated a new Quality Control facility in Sarajevo.
In detail
Useful Resources
decembar 18. 2018 |
SASE |
BSNLR - Bosnalijek d.d. Sarajevo: 12,47 3,89%